产品标题 |
产品货号 |
产品规格 |
厂家 |
UBE2D4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402473 | 1 kit | ORIGENE TECHNOLOGIES |
UBE2D2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407283 | 1 kit | ORIGENE TECHNOLOGIES |
UBE2D3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407371 | 1 kit | ORIGENE TECHNOLOGIES |
UBE2D1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405621 | 1 kit | ORIGENE TECHNOLOGIES |
Within bgcn homolog (Drosophila) (WIBG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410182 | 100 ug | ORIGENE TECHNOLOGIES |
Within bgcn homolog (Drosophila) (WIBG), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428389 | 100 ug | ORIGENE TECHNOLOGIES |
WIT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401018 | 1 kit | ORIGENE TECHNOLOGIES |
WIT1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301018 | 10 ug | ORIGENE TECHNOLOGIES |
WIZ - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422575 | 1 kit | ORIGENE TECHNOLOGIES |
Wiz - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN519440 | 1 kit | ORIGENE TECHNOLOGIES |
SCO cytochrome oxidase deficient homolog 1 (yeast) (SCO1), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY417885 | 100 ug | ORIGENE TECHNOLOGIES |
SCO cytochrome oxidase deficient homolog 2 (yeast) (SCO2), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIES | LY417499 | 100 ug | ORIGENE TECHNOLOGIES |
SCO cytochrome oxidase deficient homolog 2 (yeast) (SCO2), nuclear gene encoding mitochondrial protein, transcript variant 2 from ORIGENE TECHNOLOGIES | LY432793 | 100 ug | ORIGENE TECHNOLOGIES |
SCO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402026 | 1 kit | ORIGENE TECHNOLOGIES |
SCO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411837 | 1 kit | ORIGENE TECHNOLOGIES |
Sco1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515395 | 1 kit | ORIGENE TECHNOLOGIES |
SCO1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302026 | 10 ug | ORIGENE TECHNOLOGIES |
Sco2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515396 | 1 kit | ORIGENE TECHNOLOGIES |
Epo - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505297 | 1 kit | ORIGENE TECHNOLOGIES |
EPO - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410775 | 1 kit | ORIGENE TECHNOLOGIES |
EPOP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN425579 | 1 kit | ORIGENE TECHNOLOGIES |
Human palmitoyl-protein thioesterase 1 (PPT1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP721098 | 10 ug | ORIGENE TECHNOLOGIES |
Human palmitoyl-protein thioesterase 1 (PPT1), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760080 | 50 ug | ORIGENE TECHNOLOGIES |
Human endothelin converting enzyme 1 (ECE1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP326153 | 20 ug | ORIGENE TECHNOLOGIES |
Human endothelin converting enzyme 1 (ECE1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP323135 | 20 ug | ORIGENE TECHNOLOGIES |
Human endothelin 1 (EDN1) from ORIGENE TECHNOLOGIES | TP302217 | 20 ug | ORIGENE TECHNOLOGIES |
Human energy homeostasis associated (ENHO) from ORIGENE TECHNOLOGIES | TP323456 | 20 ug | ORIGENE TECHNOLOGIES |
Human engrailed homeobox 2 (EN2) from ORIGENE TECHNOLOGIES | TP311220 | 20 ug | ORIGENE TECHNOLOGIES |
PPPDE1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302524 | 10 ug | ORIGENE TECHNOLOGIES |
PPPDE2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH310892 | 10 ug | ORIGENE TECHNOLOGIES |
PPPDE peptidase domain containing 1 (PPPDE1) from ORIGENE TECHNOLOGIES | LY414201 | 100 ug | ORIGENE TECHNOLOGIES |
PPPDE peptidase domain containing 2 (PPPDE2) from ORIGENE TECHNOLOGIES | LY414397 | 100 ug | ORIGENE TECHNOLOGIES |
Human cylindromatosis (turban tumor syndrome) (CYLD), transcript variant 3 from ORIGENE TECHNOLOGIES | TP314451 | 20 ug | ORIGENE TECHNOLOGIES |
ECH1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305622 | 10 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564168 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564158 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564227 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564230 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564254 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564414 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564253 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564585 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564437 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564660 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564980 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564985 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564996 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD564698 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD565009 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Prostate; Adenocarcinoma of prostate from ORIGENE TECHNOLOGIES | CD565087 | 5 ug | ORIGENE TECHNOLOGIES |